NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Via Transportation, Inc. ("Via" or "the Company") (NYSE:VIA). Investors who purchased Via securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/VIA. […]

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vistagen Therapeutics, Inc. ("Vistagen" or "the Company") (NASDAQ:VTGN). Investors who purchased Vistagen securities prior to April 1, 2024, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edison International ("Edison" or "the Company") (NYSE:EIX). Investors who purchased Edison securities prior to February 25, 2021, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Distribution Solutions Group, Inc. ("DSG" or "the Company") (NASDAQ:DSGR). Investors who purchased DSG securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Unicycive Therapeutics, Inc. ("Unicycive" or "the Company") (NASDAQ:UNCY). Investors who purchased Unicycive securities prior to March 29, 2024, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of KBR, Inc. ("KBR" or "the Company") (NYSE:KBR). Investors who purchased KBR securities prior to May 6, 2025, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barclays PLC ("Barclays" or "the Company") (NYSE:BCS). Investors who purchased Barclays securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/BCS. Barclays

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Five9, Inc. ("Five9" or "the Company") (NASDAQ:FIVN). Investors who purchased Five9 securities prior to June 4, 2025, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM). Investors who purchased DexCom securities prior to January 8, 2024, and continue to hold to the present, are encouraged to obtain additional